GlaxoSmithKline And Aptuit, Inc. Finalize Agreement For Aptuit To Acquire GSK's Research Operations In Italy

LONDON & GREENWICH, Conn.--(BUSINESS WIRE)--GlaxoSmithKline (GSK) and Aptuit, Inc. announced today that they have finalized an agreement for Aptuit to acquire operations at GSK’s Medicines Research Centre in Verona, Italy. The arrangement, which is effective as of July 1, 2010, provides for ongoing employment of the staff at the centre and for Aptuit to supply GSK with R&D services from the facilities. Financial terms have not been disclosed.

Back to news